Inhibitory effect of genistein on mouse colon cancer MC-26 cells involved TGF-β1/Smad pathway

Abstract

TGF-β1/signaling has been shown to be associated with proapoptotic and antimitotic activities in epithelial tissues. Genistein, a major component of soybean isoflavone, has multiple functions resulting in anticancer proliferation. We herein showed that genistein dose-dependently increased TGF-β1 mRNA expression in mouse colon cancer MC-26 cells. A mouse monoclonal anti-TGF-β1 neutralizing antibody partially, but not completely, blocked the growth inhibition by genistein. By using adenoviral vector, we demonstrated that Smad7 overexpression attenuated genistein-induced growth inhibition and apoptosis as determined by MTT and apoptosis ELISA. Smad7 overexpression also inhibited upregulation of p21 and caspase-3 activity by geinistein. To further confirm inhibitory effect of genistein in MC-26 cells require TGF-β1/Smad signaling, we employed Western blot and electrophoretic mobility shift assay to detect formation of Smad–DNA complexes and phosphorylation of Smad2 and Smad3, respectively. Data revealed that genistein induced an evident formation of Smad–DNA complexes and phosphorylation of Smad2 and Smad3, indicating increased TGF-β1 signaling. Taken together, these findings first provided insights into possible molecular mechanisms of growth inhibition by genistein that required Smad signaling, which could aid in its evaluation for colon tumor prevention.